The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Topical Contraceptive-Global Market Insights and Sales Trends 2025
Synopsis
Contraception is deliberate prevention of pregnancy by interfering with normal process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques. Contraceptives are the drugs or devices which prevents pregnancy and sexually transmitted diseases (STDs).
The global Topical Contraceptive market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Topical Contraceptive in various end use industries. The expanding demands from the Online Stores and Retail Stores, are propelling Topical Contraceptive market. Topical Contraceptive Suppository, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Topical Contraceptive Film segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Topical Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Topical Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Topical Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Topical Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Topical Contraceptive covered in this report include Allergan, Okamoto Industries, Reckitt Benckiser, Agile Therapeutics, Bayer Pharma, Ferring Pharmaceuticals, HLL Lifecare, Lupin Pharmaceuticals and Mayer Laboratories, etc.
The global Topical Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan
Okamoto Industries
Reckitt Benckiser
Agile Therapeutics
Bayer Pharma
Ferring Pharmaceuticals
HLL Lifecare
Lupin Pharmaceuticals
Mayer Laboratories
Global Topical Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Topical Contraceptive market, Segment by Type:
Topical Contraceptive Suppository
Topical Contraceptive Film
Topical Contraceptive Pill
Others
Global Topical Contraceptive market, by Application
Online Stores
Retail Stores
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Topical Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Topical Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Contraception is deliberate prevention of pregnancy by interfering with normal process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques. Contraceptives are the drugs or devices which prevents pregnancy and sexually transmitted diseases (STDs).
The global Topical Contraceptive market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Topical Contraceptive in various end use industries. The expanding demands from the Online Stores and Retail Stores, are propelling Topical Contraceptive market. Topical Contraceptive Suppository, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Topical Contraceptive Film segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Topical Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Topical Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Topical Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Topical Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Topical Contraceptive covered in this report include Allergan, Okamoto Industries, Reckitt Benckiser, Agile Therapeutics, Bayer Pharma, Ferring Pharmaceuticals, HLL Lifecare, Lupin Pharmaceuticals and Mayer Laboratories, etc.
The global Topical Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan
Okamoto Industries
Reckitt Benckiser
Agile Therapeutics
Bayer Pharma
Ferring Pharmaceuticals
HLL Lifecare
Lupin Pharmaceuticals
Mayer Laboratories
Global Topical Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Topical Contraceptive market, Segment by Type:
Topical Contraceptive Suppository
Topical Contraceptive Film
Topical Contraceptive Pill
Others
Global Topical Contraceptive market, by Application
Online Stores
Retail Stores
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Topical Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Topical Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Topical Contraceptive Market Overview
1.1 Topical Contraceptive Product Overview
1.2 Topical Contraceptive Market Segment by Type
1.2.1 Topical Contraceptive Suppository
1.2.2 Topical Contraceptive Film
1.2.3 Topical Contraceptive Pill
1.2.4 Others
1.3 Global Topical Contraceptive Market Size by Type
1.3.1 Global Topical Contraceptive Market Size Overview by Type (2018-2029)
1.3.2 Global Topical Contraceptive Historic Market Size Review by Type (2018-2023)
1.3.3 Global Topical Contraceptive Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Topical Contraceptive Sales Breakdown by Type (2018-2023)
1.4.2 Europe Topical Contraceptive Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Topical Contraceptive Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Topical Contraceptive Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Topical Contraceptive Sales Breakdown by Type (2018-2023)
2 Global Topical Contraceptive Market Competition by Company
2.1 Global Top Players by Topical Contraceptive Sales (2018-2023)
2.2 Global Top Players by Topical Contraceptive Revenue (2018-2023)
2.3 Global Top Players by Topical Contraceptive Price (2018-2023)
2.4 Global Top Manufacturers Topical Contraceptive Manufacturing Base Distribution, Sales Area, Product Type
2.5 Topical Contraceptive Market Competitive Situation and Trends
2.5.1 Topical Contraceptive Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Topical Contraceptive Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Topical Contraceptive as of 2022)
2.7 Date of Key Manufacturers Enter into Topical Contraceptive Market
2.8 Key Manufacturers Topical Contraceptive Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Topical Contraceptive Status and Outlook by Region
3.1 Global Topical Contraceptive Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Topical Contraceptive Historic Market Size by Region
3.2.1 Global Topical Contraceptive Sales in Volume by Region (2018-2023)
3.2.2 Global Topical Contraceptive Sales in Value by Region (2018-2023)
3.2.3 Global Topical Contraceptive Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Topical Contraceptive Forecasted Market Size by Region
3.3.1 Global Topical Contraceptive Sales in Volume by Region (2024-2029)
3.3.2 Global Topical Contraceptive Sales in Value by Region (2024-2029)
3.3.3 Global Topical Contraceptive Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Topical Contraceptive by Application
4.1 Topical Contraceptive Market Segment by Application
4.1.1 Online Stores
4.1.2 Retail Stores
4.2 Global Topical Contraceptive Market Size by Application
4.2.1 Global Topical Contraceptive Market Size Overview by Application (2018-2029)
4.2.2 Global Topical Contraceptive Historic Market Size Review by Application (2018-2023)
4.2.3 Global Topical Contraceptive Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Topical Contraceptive Sales Breakdown by Application (2018-2023)
4.3.2 Europe Topical Contraceptive Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Topical Contraceptive Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Topical Contraceptive Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Topical Contraceptive Sales Breakdown by Application (2018-2023)
5 North America Topical Contraceptive by Country
5.1 North America Topical Contraceptive Historic Market Size by Country
5.1.1 North America Topical Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Topical Contraceptive Sales in Volume by Country (2018-2023)
5.1.3 North America Topical Contraceptive Sales in Value by Country (2018-2023)
5.2 North America Topical Contraceptive Forecasted Market Size by Country
5.2.1 North America Topical Contraceptive Sales in Volume by Country (2024-2029)
5.2.2 North America Topical Contraceptive Sales in Value by Country (2024-2029)
6 Europe Topical Contraceptive by Country
6.1 Europe Topical Contraceptive Historic Market Size by Country
6.1.1 Europe Topical Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Topical Contraceptive Sales in Volume by Country (2018-2023)
6.1.3 Europe Topical Contraceptive Sales in Value by Country (2018-2023)
6.2 Europe Topical Contraceptive Forecasted Market Size by Country
6.2.1 Europe Topical Contraceptive Sales in Volume by Country (2024-2029)
6.2.2 Europe Topical Contraceptive Sales in Value by Country (2024-2029)
7 Asia-Pacific Topical Contraceptive by Region
7.1 Asia-Pacific Topical Contraceptive Historic Market Size by Region
7.1.1 Asia-Pacific Topical Contraceptive Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Topical Contraceptive Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Topical Contraceptive Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Topical Contraceptive Forecasted Market Size by Region
7.2.1 Asia-Pacific Topical Contraceptive Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Topical Contraceptive Sales in Value by Region (2024-2029)
8 Latin America Topical Contraceptive by Country
8.1 Latin America Topical Contraceptive Historic Market Size by Country
8.1.1 Latin America Topical Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Topical Contraceptive Sales in Volume by Country (2018-2023)
8.1.3 Latin America Topical Contraceptive Sales in Value by Country (2018-2023)
8.2 Latin America Topical Contraceptive Forecasted Market Size by Country
8.2.1 Latin America Topical Contraceptive Sales in Volume by Country (2024-2029)
8.2.2 Latin America Topical Contraceptive Sales in Value by Country (2024-2029)
9 Middle East and Africa Topical Contraceptive by Country
9.1 Middle East and Africa Topical Contraceptive Historic Market Size by Country
9.1.1 Middle East and Africa Topical Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Topical Contraceptive Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Topical Contraceptive Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Topical Contraceptive Forecasted Market Size by Country
9.2.1 Middle East and Africa Topical Contraceptive Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Topical Contraceptive Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Allergan
10.1.1 Allergan Company Information
10.1.2 Allergan Introduction and Business Overview
10.1.3 Allergan Topical Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Allergan Topical Contraceptive Products Offered
10.1.5 Allergan Recent Development
10.2 Okamoto Industries
10.2.1 Okamoto Industries Company Information
10.2.2 Okamoto Industries Introduction and Business Overview
10.2.3 Okamoto Industries Topical Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Okamoto Industries Topical Contraceptive Products Offered
10.2.5 Okamoto Industries Recent Development
10.3 Reckitt Benckiser
10.3.1 Reckitt Benckiser Company Information
10.3.2 Reckitt Benckiser Introduction and Business Overview
10.3.3 Reckitt Benckiser Topical Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Reckitt Benckiser Topical Contraceptive Products Offered
10.3.5 Reckitt Benckiser Recent Development
10.4 Agile Therapeutics
10.4.1 Agile Therapeutics Company Information
10.4.2 Agile Therapeutics Introduction and Business Overview
10.4.3 Agile Therapeutics Topical Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Agile Therapeutics Topical Contraceptive Products Offered
10.4.5 Agile Therapeutics Recent Development
10.5 Bayer Pharma
10.5.1 Bayer Pharma Company Information
10.5.2 Bayer Pharma Introduction and Business Overview
10.5.3 Bayer Pharma Topical Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bayer Pharma Topical Contraceptive Products Offered
10.5.5 Bayer Pharma Recent Development
10.6 Ferring Pharmaceuticals
10.6.1 Ferring Pharmaceuticals Company Information
10.6.2 Ferring Pharmaceuticals Introduction and Business Overview
10.6.3 Ferring Pharmaceuticals Topical Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ferring Pharmaceuticals Topical Contraceptive Products Offered
10.6.5 Ferring Pharmaceuticals Recent Development
10.7 HLL Lifecare
10.7.1 HLL Lifecare Company Information
10.7.2 HLL Lifecare Introduction and Business Overview
10.7.3 HLL Lifecare Topical Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.7.4 HLL Lifecare Topical Contraceptive Products Offered
10.7.5 HLL Lifecare Recent Development
10.8 Lupin Pharmaceuticals
10.8.1 Lupin Pharmaceuticals Company Information
10.8.2 Lupin Pharmaceuticals Introduction and Business Overview
10.8.3 Lupin Pharmaceuticals Topical Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Lupin Pharmaceuticals Topical Contraceptive Products Offered
10.8.5 Lupin Pharmaceuticals Recent Development
10.9 Mayer Laboratories
10.9.1 Mayer Laboratories Company Information
10.9.2 Mayer Laboratories Introduction and Business Overview
10.9.3 Mayer Laboratories Topical Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mayer Laboratories Topical Contraceptive Products Offered
10.9.5 Mayer Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Topical Contraceptive Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Topical Contraceptive Industrial Chain Analysis
11.4 Topical Contraceptive Market Dynamics
11.4.1 Topical Contraceptive Industry Trends
11.4.2 Topical Contraceptive Market Drivers
11.4.3 Topical Contraceptive Market Challenges
11.4.4 Topical Contraceptive Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Topical Contraceptive Distributors
12.3 Topical Contraceptive Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Retail Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
